---
title: "INT MEDICAL invests up to 110 million RMB in a joint venture"
description: "INT MEDICAL announced related transactions and established a limited partnership with Huige Health and other limited partners - Huige Guangtai Fund, with the main goal of achieving investment returns "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/251868606.md"
published_at: "2025-08-06T15:02:22.000Z"
---

# INT MEDICAL invests up to 110 million RMB in a joint venture

> INT MEDICAL announced related transactions and established a limited partnership with Huige Health and other limited partners - Huige Guangtai Fund, with the main goal of achieving investment returns through equity investments in companies in the medical device sector. The total investment amount is expected to not exceed RMB 350 million, of which the company will contribute no more than RMB 110 million as a limited partner

INT MEDICAL (01501.HK) announced related transactions and established a limited partnership - HuaiGe GuangTai Fund with HuaiGe Health and other limited partners, with the main goal of achieving investment returns through equity investments in companies in the medical device sector. The total investment amount is expected to not exceed 350 million RMB, of which the company, as a limited partner, will contribute no more than 110 million RMB

### Related Stocks

- [01501.HK - INT MEDICAL](https://longbridge.com/en/quote/01501.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 德康医疗｜8-K：2025 财年 Q4 营收 12.6 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/275807118.md) |
| Outset Medical｜8-K：2025 财年 Q4 营收 28.87 百万美元不及预期 |  | [Link](https://longbridge.com/en/news/275659348.md) |
| Baxter｜8-K：2025 财年 Q4 营收 29.74 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/275754681.md) |
| 微创心通医疗科技有限公司召开了特别股东大会 | 微创心通医疗科技公司于 2026 年 2 月 11 日召开了特别股东大会，股东们批准了股份合并和股票期权调整的提案。该信息通过香港证券交易所的发行人信息服务发布 | [Link](https://longbridge.com/en/news/275618810.md) |
| 微创心通-B 已获得股东批准进行股份合并，该合并将于 2 月 24 日生效 | 微创医疗（MicroPort CardioFlow Medtech Corp.）已获得股东批准进行股份合并，将已发行股份从约 63.7 亿股减少至约 12.7 亿股。此次合并将于 2026 年 2 月 24 日生效，旨在提高交易效率和价格认 | [Link](https://longbridge.com/en/news/275644985.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
